PROCEPT BIOROBOTICS CORP

PROCEPT BioRobotics Corporation manufactures and markets the AquaBeam Robotic System, a surgical device that uses a high-velocity saline stream to resect prostate tissue. The system is designed for and marketed for performing transurethral prostate procedures. The company's business model is built on the commercial exploitation of animals, as its regulatory clearance and ongoing product development rely on animal testing. The AquaBeam system's 510(k) clearance by the U.S. Food and Drug Administration was predicated on preclinical studies conducted in animal models, a standard industry practice for surgical devices. As a medical robotics company, its product pipeline and future iterations of its surgical technology will necessitate further animal experimentation to demonstrate safety and efficacy for new indications or design modifications. The company derives 100% of its revenue from this product platform, making animal exploitation central to its core commercial activity.